The ability of antibody fragment F(abâ€™)2 to prevent the binding of rhinovirus with ICAM-1 receptors on the surface of the host cell and the ability of antibody fragment F(abâ€™)2 to facilitate microbial phagocytosis. Introduction: The antibody is comprised of two arms that are heavy and light chains. The heavy chains are attached by disulfide bonds. The antibodies have two regions, constant and variable regions. ICAM-1 or intercellular adhesion molecule 1 is one of the proteins encoded by gene ICAM-1. This gene encodes the glycoprotein present on the cell surface that expresses itself on the cell of the endothelium and immune system. It is one of the transmembrane protein and a member of a superfamily of immunoglobulins.

Question

Want to see the full answer?

Answer 1

Question

Chapter 24.2, Problem 1TQ

Summary Introduction

To review:

The ability of antibody fragment F(abâ€™)2 to prevent the binding of rhinovirus with ICAM-1 receptors on the surface of the host cell and the ability of antibody fragment F(abâ€™)2 to facilitate microbial phagocytosis.

Introduction:

The antibody is comprised of two arms that are heavy and light chains. The heavy chains are attached by disulfide bonds. The antibodies have two regions, constant and variable regions. ICAM-1 or intercellular adhesion molecule 1 is one of the proteins encoded by gene ICAM-1. This gene encodes the glycoprotein present on the cell surface that expresses itself on the cell of the endothelium and immune system. It is one of the transmembrane protein and a member of a superfamily of immunoglobulins.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

a) How virus vaccine, under immune system processes (via dendritic cells, T-Cells and B-Cells), can help people against real virus infection. b) Structure of SARS-CoV-2 and their entry process on host cells. Then, if you choose onetype of virus protein (spikes, nucleocapsid, membrane or envelope) should be used for vaccine,which is the best candidate? Why?

3) Would mRNA vaccines be as effective against bacteria as they are against viruses? Why or why not? Questions related to SARS-CoV-2 Inhibitor Science Article (Zhang et al.) 1) What is the function of the viral main protease? 2) What is the amino acid recognition sequence that is cleave by this main protease? Indicate where this protease cuts? 3) Would interfering with this protease effect other proteases in human cells? 4) How closely related are the amino acid sequences between SARS-CoV-2 and SARS-CoV? What does this suggest about focusing research on inhibiting this enzyme?

Moderna and Pfizer vaccines for COVID-19 use mRNA to the Spike protein combined with lipids. Which of the following is/are advantages of this type of vaccine compared to an inactivated virus vaccine? Select ALL correct answers. a) The vaccine is more stable for transport. b) The vaccine does not contain the virus so it cannot give you COVID-19. c) The vaccine can be rapidly produced in a slightly different form to protect from variants of SARS-CoV-2. d) The vaccine does not need a booster.